L

Leslie Cottle

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

4 papers and 1.3k citations.

4Publications

1.3kTotal Citations

Top publicationsby citations

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz, Sheldon D. Fields, Eileen F. Dunne et al.|New England Journal of Medicine|2021

Cited by 847

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial

Raphael J. Landovitz, Joseph J. Eron, Sue Li et al.|PLoS Medicine|2018

Cited by 171

Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

Raphael J. Landovitz, Craig W. Hendrix, Sue Li et al.|The Lancet HIV|2020

Cited by 171

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Elizabeth E. Tolley, Raphael J. Landovitz, Sahar Z. Zangeneh et al.|AIDS and Behavior|2020

Cited by 92

Indexing the rest of 4 publications…